21St Century Oncology Holdings, Inc. (RTSX) SEC Filing 10-Q Quarterly report for the period ending Wednesday, September 30, 2015

 21ST CENTURY ONCOLOGY HOLDINGS, INC.

 CONDENSED CONSOLIDATED BALANCE SHEETS

 (in thousands, except share amounts)

 (unaudited)

PRELIMINARY

ADJUSTMENTS

FINAL

September 30,

September 30,

September 30,

2015

2015

2015

ASSETS

Current assets:

Cash and cash equivalents

$

47,793

$

—

$

47,793

Restricted cash

80

—

80

Marketable securities

622

—

622

Accounts receivable, net

149,224

—

149,224

Prepaid expenses

9,381

—

9,381

Inventories

5,162

—

5,162

Deferred income taxes

191

—

191

Other

8,056

—

8,056

Total current assets

220,509

—

220,509

Equity investments in joint ventures

1,236

—

1,236

Property and equipment, net

249,392

—

249,392

Real estate subject to finance obligation

11,625

—

11,625

Goodwill

492,084

—

492,084

Intangible assets, net

74,434

—

74,434

Other assets

49,282

—

49,282

Total assets

$

1,098,562

$

—

$

1,098,562

LIABILITIES AND EQUITY

Current liabilities:

Accounts payable

$

59,397

$

—

$

59,397

Accrued expenses

111,084

28,977

A

140,061

Income taxes payable

1,814

—

1,814

Current portion of long-term debt

30,858

—

30,858

Current portion of finance obligation

481

—

481

Other current liabilities

6,484

—

6,484

Total current liabilities

210,118

28,977

239,095

Long-term debt, less current portion

1,009,196

—

1,009,196

Finance obligation, less current portion

12,057

—

12,057

Embedded derivative & other financial instrument features of Series A convertible redeemable preferred stock

23,541

3,798

B

27,339

Other long-term liabilities

39,861

—

39,861

Deferred income taxes

3,716

—

3,716

Total liabilities

1,298,489

32,775

1,331,264

Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 authorized, 385,000 issued and outstanding at September 30, 2015 and December 31, 2014

404,179

(33,701

)

C

370,478

Noncontrolling interests - redeemable

19,934

—

19,934

Commitments and Contingencies

Equity:

Common stock, $0.01 par value, 1,000,000 shares authorized 1,059 and 1,028 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively

—

—

—

Additional paid-in capital

569,036

30,697

D

599,733

Retained deficit

(1,174,400

)

(29,771

)

E

(1,204,171

)

Accumulated other comprehensive loss, net of tax

(45,008

)

—

(45,008

)

Total 21st Century Oncology Holdings, Inc. shareholder’s deficit

(650,372

)

926

(649,446

)

Noncontrolling interests - nonredeemable

26,332

—

26,332

Total deficit

(624,040

)

926

(623,114

)

Total liabilities and equity

$

1,098,562

$

—

$

1,098,562